It’s hard to believe but Pfizer (PFE, $19.91, down $0.06) is below $20 again. After months of treading water above $20, the stock will now try to hold down the high teens. Pfizer has been in a 5-year downtrend after hitting a high of nearly $50 in 2000. The companyRead more

More